Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
() -- Johnson & Johnson (JNJ) said Wednesday that the US Food and Drug Administration has approved its Dual Energy Thermocool Smarttouch SF Platform. The company said the platform is an integrated catheter ablation product that is intended to allow electrophysiologists to provide radiofrequency and pulsed field energy
The Dual Energy THERMOCOOL SMARTTOUCH SF Platform (DE STSF), an integrated catheter ablation solution that enables electrophysiologists to deliver both radiofrequency (RF) and pulsed field (PF) energy through a single catheter.i "The FDA approval of the Dual Energy THERMOCOOL SMARTTOUCH SF Platform is another important